We investigated the relative contribution of the two Escherichia coli DNA alkyltransferases (ATases) to the increased sensitivity of ATase-deficient bacteria to the mutagenic and lethal effects of chloroethylnitrosoureas (CNU). The ogtencoded protein was the principal determinant in resistance to the mutagenic effects of CNU in E.coli. Thus, only when the ogt gene was inactivated was sensitivity to mutagenesis greatly increased; the contribution of inactivation of the ada gene was relatively minor. Furthermore, induction of the adaptive response provided essentially no protection against CNU mutagenesis in either an ogt + or ogt~ background. Finally, overexpression of the ogt gene into ogt ã da~ double mutants provided the greatest protection against CNU; introduction of the full-length or truncated ada gene was protective, but to a much lesser extent. Mammalian ATases were not as protective against mutation induction by CNU as Ogt, even though they were apparently expressed at higher level. In order of effectiveness the ATases ranked Ogt > human > truncated Ada = Ada > rat This order was not observed in the protection against killing by l-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea, where truncated Ada = human > Ogt > rat = Ada. Higher mutation frequency and toxicity were observed in uvrm utants, suggesting that one or more of the potentially mutagenic and/or toxic lesions are also substrates for the excision repair proteins.
Introduction
Chloroethylnitrosoureas (CNU*) are active anti-cancer agents that are being used for treatment of Hodgkin's and nonHodgkin's lymphomas, tumors of the brain, gastrointestinal tract and lung and some other neoplasic diseases. Two representatives of the group are l-(2-chloroethyl)-3-cyclohexyl-lnitrosourea (lomustine, CCNU) and l,3-bis(2-chloroethyl)-lnitrosourea (carmustine, BCNU). BCNU was introduced for cancer treatment in 1966 and CCNU in 1969 (1) . In addition to their anti-tumor activity, CNU are also mutagenic, inducing both point mutations and cytogenetic effects, and there is sufficient evidence for their carcinogenicity in experimental animals. They may well therefore also contribute to the long-term carcinogenic effects of combination chemotherapy of human cancer (1, 2) .
The effectiveness of many chemotherapeutic agents used in the treatment of human tumors is a consequence of their ability to modify DNA. CNU are highly reactive compounds that break down by a pathway similar to that described for alkylnitrosamides, to produce the chloroethyl carbonium ion, a bifunctional alkylating species (3) . This generates DNA monoadducts, as do monofunctional alkylating agents, but also cyclized derivatives and DNA inter-and intrastrand crosslinks (4) .
The lethal effects of CNU are thought to be mediated by DNA interstrand cross-links that are formed through the initial alkylation of the Opposition of guanine (4, 5) . This rapid step is followed by the formation of cyclic C^A'-ethanoguanine and cross-linking from the N 1 of guanine to the N 3 position of a cytosine residue on the opposite strand. DNA repair by mammalian C^-alkylguanine-DNA alkyltransferase (ATase) can attenuate the cytotoxic effects of CNU by recognizing and removing the chloroethyl group from the O 6 position of guanine and hence preventing the subsequent cyclization and guaninecytosine interstrand cross-linking (6) . In so doing, the ATase is inactivated and the extent of repair that occurs in a cell is therefore dependent on the amount of repair protein present and the de novo synthesis rate. Another reaction that can occur is the covalent binding of the ATase to the cyclic guanine derivative, but the biological significance of this ATase-DNA complex is not yet established (7, 8) .
Escherichia coli has two different ATases: the constitutively expressed 19 kDa ogt gene product (9) and the inducible 39 kDa ada gene product (10) (11) (12) , which is composed of two domains of 18 and 20 kDa respectively. The ogr-encoded protein (Ogt) mediates the irreversible transfer of alkyl groups from C^-alkylguanine and also 0 4 -alkylthymine to a specific cysteine residue in the alkyltransferase itself. The 18 kDa domain of the ada-encoded ATase (Ada) has a similar repair function. However, Ada has an additional active site cysteine residue in the 20 kDa domain that transfers alkyl groups from alkylphosphotriesters. Once alkylated at this position, Ada becomes a positive regulator that induces expression of the ada-alkB operon and other genes during the adaptive response that is initiated by methylating agents (12, 13) . In wild type, non-adapted E.coli the predominant ATase is that encoded by ogt (14) (15) (16) .
Kinetic experiments with synthetic oligonucleotides containing modified bases have revealed important differences between die two bacterial DNA ATases. Thus, Ogt has been found to be 173 times faster than Ada in removing O 6 -ethylguanine, both repair proteins acting, however, at approximately the same rate on O*-methylguanine (17) . In agreement with such in vitro substrate specificity studies, we have demonstrated that inactivation of the ogt gene sensitizes the bacterial cells to mutagenesis by ethylating (18) and also propylating compounds (19) . In comparison, sensitization to NAbril et aL (18, 20) . The E.coli ATases also show gross structural differences from their mammalian counterparts (21) , suggesting potential differences in substrate specificity. Indeed, it has recently been shown that repair of C^-alkylthymine is not ATase mediated but excision repair-dependent in human cells (22) . We recently demonstrated that ogt ~ ada ~ null mutants had increased sensitivity to both the mutagenic and lethal effects of CCNU. The mutation spectra induced by CCNU in the lacl gene of bacteria proficient (ogt + ada + ) or deficient (ogt ~ ada ') in ATases further demonstrated that this DNA repair system plays an important role in the processing of those CCNUinduced lesions reponsible for GC-»AT transitions and in the DNA sequence specificity of CCNU-induced mutagenesis (23) .
In this study we have investigated the relative contribution of the two E.coli ATases to the increased sensitivity of ATasedeficient E.coli to the mutagenic and lethal effects of CNU. To this end, ogt ~ and ada ~ single mutants have been compared with otherwise isogenic ogt~ ada' double mutant and their ogt + ada + parental counterparts, We have also examined ogf ada ~ null mutants overexpressing either E.coli or recombinant mammalian ATases, in order to further explore species differences between prokaryotic and eukaryotic proteins.
Materials and methods

Bacterial strains and plasmids
The E.coli K-12 strains and the plasmids used in this study are described in Table I . UC8310 (uvO. UC575 (ogf) and UC838 (uvr~ ogt-) were previously isolated in our laboratory (24, 25) . UC1033 (used as wild type), UC1012 (uvr~ ada~) and UC1011 (uvr' ogt~ ada') are derivative strains constructed by P1 vi'r-mediated transduction. UC978 is equivalent to UC1011 except for the ogt ~ deficiency; UC978 an ogtI::K.an' disruption mutation and UC10U a A (ogt-Jhr)] deletion. Strains overproducing bacterial (UC1063, UC1065 and UC1095) or recombinant rat (UC1094) or human (UC1089) ATases were isolated by transformation of UC978 with the plasmids listed in Table I . Control strains (UC1064 and UC1086) carrying cloning vectors were also obtained. All genetic manipulations and strain constructions were performed as described by Curtis (31) . Media were according to Davis et al. (32) .
Mutagens
CCNU was purchased from Aldrich (Milwaukee, Wl), BCNU was kindly provided by Bristol-Myers Squibb Co. (Evansville, IN), A'-rutroso-A''-methyl-A'-nitrosoguanidine (MNNG) and ethyl methanesulfonate (EMS) were from Sigma (St Louis, MO). Mutagens were dissolved in A'A-dimethylformamide (CCNU), absolute ethanol (BCNU) or dimethyl sulfoxide (MNNG and EMS). Solvents were from Merck (Darmstadt, Germany).
Mutagenesis and survival assays
Mutagenesis was assayed by means of the so-called L-arabinose (Ara) resistance test (33, 34) . The Ara test uses a strain mutated in gene araD (Ara 1   ) as an indicator of mutagenicity and selects forward mutations to L-arabinose resistance (Ara 1 ) in a medium containing L-arabinose and a carbon source (glycerol) which is unable to repress araDAB operon expression. The mutagenesis protocol was earned out basically as previously described (34, 35) . Briefly, bacteria were grown at 37°C for 12 h with shaking (90 r.p.m.) in LB nutrient medium (32) . Cells were then harvested by centrifugation and resuspended in 0.2 M phosphate buffer, pH 7.4. An aliquot of bacterial suspension (containing 4X10 7 cells) and the mutagen to be tested were preincubated at 37°C for 40 min with shaking (90 r.p.m.) in 1 ml phosphate buffer. Aliquots of 0.25 ml (~10 7 bacteria) were then combined in 2 ml molten top agar containing a trace amount of 0.5 mg D-glucose, for full expression of Ara r mutants (33) , and the contents poured on selective plates. Pre-incubations with the mutagen solvent were included for spontaneous counts. Selective plates for Ara r mutants were as follows: VB salts (32) containing Difco agar (17 g/1), L-arabinose (2 g/1), glycerol (2 g/1), arginine (40 |ig/ml), D-biotin (5 Hg/ml), thiamine (5 Hg/ml), nicotinic acid (5 Hg/ml) and adenine (100 |ig/ml). Bacterial colonies were counted automatically (Analytical Measuring System Ltd, UK; model . All data represent averages from at least two duplicate plates. Each mutagenesis assay was repeated on at least two separate occasions using a wide range of mutagen concentrations. A treatment was considered mutagenic when a dose-response curve was produced and when more than twice the spontaneous background number of mutants were induced at, at least, one dose. For survival determinations, aliquots of 0.1 ml were withdrawn from the pre-incubation mixtures after 40 min exposure. Bacteria were then diluted in VB salts and plated in LB nutrient agar. Strains with plasmids were grown in the presence of ampicillin (50 Hg/ml).
Results
The E.coli uvrB' strain (UC831O) was more sensitive to both the mutagenic effects, as measured by the induction of forward mutations to L-arabinose resistance (AraO, and the lethal effects of CCNU than was the uvrB + wild-type (UC1O33) (Figure 1 ). This agrees with previous studies in which uvrA' mutant strains had a marked increase in sensitivity to the lethal effects of BCNU (36, 37) . A similar increase in sensitivity to CCNU was seen in the uvrB + strain upon introducing a mutation into the ogt gene (UC575), but the uvrB~ ogt~ double mutant (UC838) had vastly increased susceptibility to killing and mutagenesis by CCNU. In all our subsequent experiments, the contribution of the UvrABC excision pathway to the repair of The ogt gene is cloned into pUC19, the ada gene into pSV2 and the truncated version of ada and the cDNA mammalian sequences into pUC8.1. Data are referred to control strain with pUC8.1, since other control bacteria gave similar results.
DNA damage induced by CNU and their biological effects was circumvented by using E. coli carrying a A (uvrB-bio) mutation.
In such a uvr~ genetic background, E. coli ada~ mutants (UC1012) had no or only a slight increase in susceptibility to mutagenesis by either CCNU or BCNU (Figure 2 ). In contrast, ogt deletion (UC838) caused a marked increment in mutation induction by these compounds. An additional ada ~ mutation to produce ogt' ada ~ double mutants (UC1011) had relatively little impact on mutation induction by both CNU (Figure 2 ). Since mutagenesis by CCNU and BCNU was attenuated to the greatest extent by the presence of the ogf-encoded ATase, it is not unreasonable to suggest that this DNA repair protein plays the principal role in protection against the mutagenic effect of these agents. The role of both DNA alyltransferases in preventing cytotoxicity by CCNU and BCNU was also assessed (Figure 2) . Inactivation of ada gene had little or no effect on susceptibility to the lethal effects of CNU; ogtm utants were markedly more sensitive, but ogt ~ ada ~ double mutants showed the greatest sensitivity.
Failure of CNU-induced damages to induce the synthesis of the ada-encoded ATase (38) might explain the lack of enhanced sensitivity to CNU mutagenesis of ada' bacteria as compared with ada + wild-type cells. To exclude this possibility, the role of Ada protein in mutagenesis by CNU was further investigated by adapting exponential phase cells by growth in low concentration of MNNG (Table II) , according to a protocol optimized by others (39) . As anticipated, the induction of the adaptive response provided extensive protection against the mutagenic effects of a challenging dose of MNNG. In contrast, the mutagenicity of CCNU remained essentially unchanged, either in the presence or the absence of the ogf-encoded ATase.
The possibility that Ogt ATase might be inactivated upon CCNU treatment was investigated by measuring the effect of CCNU pre-treatment on mutation induction by EMS ( III). As previously shown (18, 19) EMS was considerably more mutagenic in an ogt' strain than in an ogt + strain. Pretreatment of ogt + bacteria with CCNU greatly increased the sensitivity to mutation induction by EMS, though not to the level caused by inactivating the ogt gene (Table III) .
The ability of Ogt to protect E.coli against the deleterious effects of CNU was compared with that of Ada, a truncated Ada version and the human and rat ATases by introducing multicopy plasmids encoding these proteins into ogt~ adad ouble mutants (Figure 3 ). The Tada version retains the C^-alkylguanine/C^-alkylthymine ATase domain (but not the alkylphosphotriester ATase segment) (40) . Comparison between the full-length E.coli 39 kDa Ada protein and the truncated version is mandatory, since important differences have recently been observed in the in vitro repair of O 6 -ethylguanine substrate by the 39 kDa Ada protein as compared with the catalytic C-terminus alone (41) . None of the ATases were as effective as Ogt in protecting against the mutagenic effects of CCNU, even though they were apparently expressed at higher level (Table IV) . Indeed, the rat ATase cDNAtransformed E.coli exhibited more than 200 times more ATase activity than the ogt transformed clone but this provided less "Cells (1 ml of an overnight culture) were harvested by centrifugation (10 000 g, 2 min), resuspended in 1 ml buffer (50 mM Tris-HCl, 1 mM EDTA, 3 mM DTT, pH 8.3) and sonicated on ice. Immediately after sonication, a 0 01 vol. of phenylmethylsulfonyl fluoride (8.7 mg/ml in ethanol) was added and the extracts centrifuged (2000 g, 5 min, 0°C). Supernatants were removed and assayed for total ATase activity using as substrate highly purified calf thymus DNA, methylated with [ protection than any of the other ATases, assuming that all of this protein is available for DNA repair in vivo. In order of effectiveness the ATases ranked Ogt > human > truncated Ada = Ada > rat. This order was not observed in the protection against killing by CCNU, where truncated Ada = human > Ogt > rat = Ada (Figure 3 ).
Discussion
The involvement of mammalian C^-alkylguanine-DNA alkyltransferase in promoting resistance to CNU became apparent from the landmark paper of Erickson et al. (5) . This knowledge has been used to increase the sensitivity of resistant mammalian cells by depleting their ATase content. Here we study the contribution of the two E.coli ATases to bacterial cytotoxicity and mutagenesis due to CNU.
The data indicate that of the two E.coli ATases, the ogtencoded protein is the principal determinant in resistance to the mutagenic effects of CNU in E.coli. Thus, only when the ogt gene was inactivated was sensitivity to mutagenesis by both CCNU and BCNU greatly increased; the contribution of inactivation of the ada gene was relatively minor. Since the og/-encoded protein accounts for >80% (19, 42) of the total of ~30 ATase molecules in unadapted cells (43) , the relative contribution of both ATases was further analyzed by induction of the adaptive response. Adaptation, which produced a very substantial protection against the mutagenic effects of MNNG (thus showing that the response had indeed been induced), provided essentially no protection against CCNU mutagenesis in either an ogt + or ogt~ background. Finally, overexpression of high levels of the full-length or truncated ada + gene was somewhat protective against mutation induction by CCNU, but to a much lesser extent than overexpression of the ogt + gene. In fact, bacteria overproducing Ada or Tada retained, on average, ~35% of the mutagenic sensitivity of the parental cells, whereas overexpression of Ogt completely suppresses sensitivity of the ogt ' ada ~ double mutants to CCNU mutagenesis. These results are in agreement with previous data showing that the pre-mutagenic lesions induced by BCNU involve DNA repair mechanisms that are independent of Ada (37) .
Protection against the toxic effects of CNU did not follow exactly the same pattern as mutation induction. Thus, ogt' ada ~ double mutants were more sensitive to the lethal effects of both CCNU and BCNU than ogt~ ada + bacteria, although inactivation of the ada gene in an ogt + background had little or no influence on susceptibility to killing. In contrast, ogts ingle mutants were markedly more sensitive than the corresponding ogt + parental cells. Furthermore, introduction into ogt ' ada ' E.coli of plasmids containing the entire ada coding region provided less protection than plasmids containing the ogt gene, but overexpression of the truncated ada gene yielded the highest resistance.
The mechanism of Ogt protection against CNU mutagenesis is likely to be mainly the removal of the chloroethyl group from the O 6 position of guanine, thus preventing mispairing with thymine upon DNA replication. Such mispairing is envisaged as the source of GC->AT transitions which are the predominant type of mutations induced in uvr~ bacteria by chloroethylating compounds (23) . As the same initial lesions are considered to be principally responsible for the toxic effects of CNU, it might be anticipated that protection against killing would follow that against mutation induction, but this does not appear to actually be the case in these studies.
Around 4% of CCNU-induced mutations are targeted at A:T base pairs in both prokaryotic (23) and eukaryotic cells, where they increase up to 13% with CCNU concentration (44) . A:T targeted mutations, but in particular AT->GC transitions, are attributed to a putative (T'-chloroethylthymine lesion (44) . As the ogr-encoded ATase repairs (T'-methylthymine and longer alkyl chain derivatives of C^-alkylguanine much more efficiently than the ada ATase (17), one possible explanation for the different outcomes that Ogt or Ada deficiency have on mutation and killing by CCNU is that the postulated O 4 -chloroethylthymine lesion contributes more to mutation than to toxicity. Alternatively, the DNA sequence context in which particular C^-chloroethylguanine lesions are located may be a critical factor in determining their mutability and cytotoxicity and also the repair efficiency by different ATases (23) . Indeed, when mammalian ATases were expressed in an ogt' ada' background, apparently very high levels of expression were not as protective against mutation induction as much lower levels of Ogt, so that substrate or sequence context effects may also apply for the mammalian ATases. Such effects may have important implications in chemotherapy, modulating both the therapeutic (cytotoxicity) and the carcinogenic/mutagenic properties of anti-tumor CNU.
Expression of Ogt in endogenous ATase-deficient mammalian cells has been shown to be more effective than expression of Ada in protecting against the growth inhibitory effects of CNU and related agents, including A f -ethyl-A'-nitrosourea and AZ-butyl-N-nitrosourea (45) . This is consistent with the more efficient repair of the corresponding C^-alkylguanine and/or (T'-alkylthymine lesions in DNA. In the view of the present results, it will now be interesting to examine the effects of prokaryotic ATase expression on mutation induction in mammalian cells.
In this study recombinant human ATase overexpressed in ogt' ada~ defective bacteria was close to Ogt in suppressing both cytotoxicity and mutagenesis by CCNU, suggesting that this bacterial protein might be a suitable model for extrapolation to situations involving human cells exposed to chloroethylating drugs. Comparatively, rat ATase turned out to be much less efficient than the human counterpart, suggesting functional differences between these two proteins, although they do not show differential sensitivity to in vitro inactivation by O 6 -benzylguanine (46) .
The mechanism of the contribution of the excision repair proteins in CNU-induced mutation and killing processes should also be considered in E.coli. The higher mutation frequency and toxicity in uvr~ mutants suggests that one or more of the potentially mutagenic and/or toxic lesions might be substrates for these enzymes. This repair pathway may be particularly relevant to the in vivo fate of the ATase-DNA crosslinks that have been demonstrated in chloroethylated DNA in vitro (7, 8) . Such complexes might be substrates for the Uvr system and the efficiency of their repair might be influenced by the ATase involved and/or the sequence context in which they are formed. It will therefore be essential to take into account the effectiveness of the equivalent mammalian systems when considering the mechanism of cell killing and mutagenesis by CNU and related agents in the context of cancer chemotherapy.
